OCC 7.29% 51.5¢ orthocell limited

Ann: CelGro Study Results Open Up New US Market Access Strategy, page-67

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 518 Posts.
    lightbulb Created with Sketch. 257
    Hi Jayze87,

    Great video. Paul is developing a very positive persona. Maybe it has something to do with his confidence that good news is on its way.

    I am really looking forward to the May announcement Paul mentioned regarding the 12 month update on the CelGro nerve trial. The way Paul made the announcement he seems rather confident of a very positive outcome.

    This could be huge.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
51.5¢
Change
0.035(7.29%)
Mkt cap ! $107.9M
Open High Low Value Volume
50.5¢ 53.0¢ 50.0¢ $1.329M 2.593M

Buyers (Bids)

No. Vol. Price($)
2 28629 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
51.5¢ 11758 1
View Market Depth
Last trade - 16.10pm 08/10/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.